These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 702659)

  • 21. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous precipitation of brushite in urine: evidence that brushite is the nidus of renal stones originating as calcium phosphate.
    Pak CY; Eanes ED; Ruskin B
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1456-60. PubMed ID: 5283935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
    Tiselius HG
    Urol Res; 1997; 25(2):153-9. PubMed ID: 9144885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
    Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
    Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.
    Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A
    Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New methods of assessing crystal growth and saturation of brushite in whole urine: effect of pH, calcium and citrate.
    Pak CY; Rodgers K; Poindexter JR; Sakhaee K
    J Urol; 2008 Oct; 180(4):1532-7. PubMed ID: 18710766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts.
    Leppla D; Browne R; Hill K; Pak CY
    J Clin Endocrinol Metab; 1983 Nov; 57(5):920-4. PubMed ID: 6619267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
    Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
    J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graphic display of urinary risk factors for renal stone formation.
    Pak CY; Skurla C; Harvey J
    J Urol; 1985 Nov; 134(5):867-70. PubMed ID: 4057368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
    Sakhaee K; Nicar M; Hill K; Pak CY
    Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
    Asplin JR; Parks JH; Coe FL
    Kidney Int; 1997 Dec; 52(6):1602-8. PubMed ID: 9407506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary saturation measurements in calcium nephrolithiasis.
    Weber DV; Coe FL; Parks JH; Dunn MS; Tembe V
    Ann Intern Med; 1979 Feb; 90(2):180-4. PubMed ID: 443649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine composition and stone formation during treatment with acetazolamide.
    Ahlstrand C; Tiselius HG
    Scand J Urol Nephrol; 1987; 21(3):225-8. PubMed ID: 3433023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal stones and urinary pH.
    Metheny N
    Am J Nurs; 1982 Sep; 82(9):1372-5. PubMed ID: 6921926
    [No Abstract]   [Full Text] [Related]  

  • 36. Magnesium therapy for nephrolithiasis.
    Massey L
    Magnes Res; 2005 Jun; 18(2):123-6. PubMed ID: 16100850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discriminant score.
    Pak CY; Galosy RA
    Am J Med; 1980 Nov; 69(5):681-9. PubMed ID: 7435510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of calcium oxalate nephrolithiasis after calcium or combined calcium and calcitriol supplementation in postmenopausal women.
    Domrongkitchaiporn S; Ongphiphadhanakul B; Stitchantrakul W; Piaseu N; Chansirikam S; Puavilai G; Rajatanavin R
    Osteoporos Int; 2000; 11(6):486-92. PubMed ID: 10982163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.
    Woelfel A; Kaplan RA; Pak CY
    Metabolism; 1977 Feb; 26(2):201-5. PubMed ID: 834153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.